New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Phase 1/2a study: Safety and efficacy of new inhibitor in patients with advanced solid and CNS tumors

Phase 1/2a study: Safety and efficacy of new inhibitor in patients with advanced solid and CNS tumors

by Public Relations Pacific LLCCredit: Pixabay/CC0 Public DomainAn early-phase study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine al
World medicine December 04,2023
Phase 1/2a study: Safety and efficacy of new inhibitor in patients with advanced solid and CNS tumors

Phase 1/2a study: Safety and efficacy of new inhibitor in patients with advanced solid and CNS tumors

by Public Relations Pacific LLCCredit: Pixabay/CC0 Public DomainAn early-phase study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine al
World medicine December 04,2023
Scientists identify cellular signaling pathway as key player in metastasis

Scientists identify cellular signaling pathway as key player in metastasis

byMemorial Sloan Kettering Cancer CenterA quiescent cluster of lung adenocarcinoma tumor cells from a patient's lymph node shows low STING expression. Credit: Massagué Lab, Sloan Kettering I
World medicine December 04,2023
Scientists identify cellular signaling pathway as key player in metastasis

Scientists identify cellular signaling pathway as key player in metastasis

byMemorial Sloan Kettering Cancer CenterA quiescent cluster of lung adenocarcinoma tumor cells from a patient's lymph node shows low STING expression. Credit: Massagué Lab, Sloan Kettering I
World medicine December 04,2023
Research autopsies reveal how incurable skin cancer resists treatment

Research autopsies reveal how incurable skin cancer resists treatment

byCancer Research UKMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaScientists have determined how some skin cancers stop responding to treatment at th
World medicine December 04,2023
Research autopsies reveal how incurable skin cancer resists treatment

Research autopsies reveal how incurable skin cancer resists treatment

byCancer Research UKMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaScientists have determined how some skin cancers stop responding to treatment at th
World medicine December 04,2023
Adding dostarlimab improves progression-free survival in endometrial cancer

Adding dostarlimab improves progression-free survival in endometrial cancer

by Elana GotkineFor patients with primary advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel increases progression-free survival versus carboplatin-paclitaxel alone, acc
World medicine December 04,2023
Adding dostarlimab improves progression-free survival in endometrial cancer

Adding dostarlimab improves progression-free survival in endometrial cancer

by Elana GotkineFor patients with primary advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel increases progression-free survival versus carboplatin-paclitaxel alone, acc
World medicine December 04,2023
Six-year follow-up data on survival, benefits for patients with metastatic NSCLC and nivolumab + ipilimumab treatment

Six-year follow-up data on survival, benefits for patients with metastatic NSCLC and nivolumab + ipilimumab treatment

by International Association for the Study of Lung CancerCredit: CC0 Public DomainResearch findings from the CheckMate 227 trial will be presented at the International Association for the Study of Lun
World medicine December 04,2023
Six-year follow-up data on survival, benefits for patients with metastatic NSCLC and nivolumab + ipilimumab treatment

Six-year follow-up data on survival, benefits for patients with metastatic NSCLC and nivolumab + ipilimumab treatment

by International Association for the Study of Lung CancerCredit: CC0 Public DomainResearch findings from the CheckMate 227 trial will be presented at the International Association for the Study of Lun
World medicine December 04,2023
Tumor avatars to fight colorectal cancer

Tumor avatars to fight colorectal cancer

byUniversity of GenevaThe research team worked with organoids derived from untreated cancer tissue taken from patients. Credit: UNIGEHow to determine the most effective treatment for colon cance
World medicine December 04,2023
Tumor avatars to fight colorectal cancer

Tumor avatars to fight colorectal cancer

byUniversity of GenevaThe research team worked with organoids derived from untreated cancer tissue taken from patients. Credit: UNIGEHow to determine the most effective treatment for colon cance
World medicine December 04,2023
New program shows promise in reducing financial burden of cancer care

New program shows promise in reducing financial burden of cancer care

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainThe rising cost of cancer care puts patients and their caregivers at increased risk of experiencing financial toxicity,
World medicine December 04,2023
New program shows promise in reducing financial burden of cancer care

New program shows promise in reducing financial burden of cancer care

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainThe rising cost of cancer care puts patients and their caregivers at increased risk of experiencing financial toxicity,
World medicine December 04,2023
Pathogenic genetic variations found to boost the risk of H. pylori–related stomach cancer

Pathogenic genetic variations found to boost the risk of H. pylori–related stomach cancer

byRIKENPathogenic Variant and H. pylori Infection on Gastric Cancer Risk. Credit: RIKENA large case-control study by international researchers at the RIKEN Center for Integrative Medical Science
World medicine December 04,2023
Pathogenic genetic variations found to boost the risk of H. pylori–related stomach cancer

Pathogenic genetic variations found to boost the risk of H. pylori–related stomach cancer

byRIKENPathogenic Variant and H. pylori Infection on Gastric Cancer Risk. Credit: RIKENA large case-control study by international researchers at the RIKEN Center for Integrative Medical Science
World medicine December 04,2023
'Search and destroy' treatment found to improve quality of life for patients with advanced prostate cancer

'Search and destroy' treatment found to improve quality of life for patients with advanced prostate cancer

byInstitute of Cancer ResearchProstate cancer cell. Credit: Anne Weston, Francis Crick Institute.A new radioactive medicine that seeks out tumor cells to deliver a targeted dose of radiation gre
World medicine December 04,2023
'Search and destroy' treatment found to improve quality of life for patients with advanced prostate cancer

'Search and destroy' treatment found to improve quality of life for patients with advanced prostate cancer

byInstitute of Cancer ResearchProstate cancer cell. Credit: Anne Weston, Francis Crick Institute.A new radioactive medicine that seeks out tumor cells to deliver a targeted dose of radiation gre
World medicine December 04,2023
Predicting neuroblastoma outcomes with molecular evolution

Predicting neuroblastoma outcomes with molecular evolution

by Justin Jackson , Medical XpressEarly genomic instability is associated with unfavorable outcome. a, Enrichment of chromosomal aberrations and clinical parameters in early- and late-MRCA tumors pred
World medicine December 04,2023
Predicting neuroblastoma outcomes with molecular evolution

Predicting neuroblastoma outcomes with molecular evolution

by Justin Jackson , Medical XpressEarly genomic instability is associated with unfavorable outcome. a, Enrichment of chromosomal aberrations and clinical parameters in early- and late-MRCA tumors pred
World medicine December 04,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com